BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17611180)

  • 1. [Cardiovascular prevention with peripheral artery disease].
    Vértes A
    Orv Hetil; 2007 Jul; 148(28):1303-9. PubMed ID: 17611180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B; Henriksson M; Lundin F; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 6. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
    Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
    Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular prevention in type 2 diabetic patients: review of efficacious treatments.
    Goderis G; Boland B
    Acta Clin Belg; 2004; 59(6):329-39. PubMed ID: 15819377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.
    Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D
    Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
    Singer DR; Kite A
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk prevention in peripheral artery disease.
    Hackam DG
    J Vasc Surg; 2005 Jun; 41(6):1070-3. PubMed ID: 15944615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Hypertension Education Program. Brief overview of 2004 recommendations.
    Campbell N;
    Can Fam Physician; 2004 Oct; 50():1411-5. PubMed ID: 15526879
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease.
    Thatipelli MR; Pellikka PA; McBane RD; Rooke TW; Rosales GA; Hodge D; Herges RM; Wysokinski WE
    J Vasc Surg; 2007 Jul; 46(1):62-70; discussion 70. PubMed ID: 17583463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral arterial disease.
    Hiatt WR; Nehler MR
    Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
    [No Abstract]   [Full Text] [Related]  

  • 18. [The best of vascular medicine in 2006].
    Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction?
    Lloyd GM; Newton JD; Norwood MG; Franks SC; Bown MJ; Sayers RD
    J Vasc Surg; 2004 Oct; 40(4):691-7. PubMed ID: 15472596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.